SPARC partners with UCSF and Tiller Therapeutics to license oncology asset EP News Bureau Dec 17, 2024 Agreement grants SPARC equity in Tiller for development and commercialisation of joint oncology intellectual property
Genetics has revolutionised patient selection for clinical trials Akanki Sharma Jun 30, 2020 Genetics is questioning the wisdom behind the old gold standard of randomised populations used for trials. While large randomised…
‘Nearly 70 drugs that may be effective against coronavirus identified’ Press Trust of India Mar 26, 2020 According to the researchers, some of the medications are already used to treat diseases such as diabetes and hypertension, and…
